Hormone Therapy News

Adolescents with Prader-Willi syndrome who continued growth hormone therapy after they reached adult height did not maintain bone density, according to findings published in Clinical Endocrinology.

In recent years, news headlines about professional athletes, notably cyclists and baseball players, have brought attention to the ongoing problem of doping in professional sports. Likewise, Olympic athletes from around the world have been disqualified for using performance-enhancing drugs in various sports.

Adolescents who created real-world diets attempting to avoid exposure to bisphenol A, or BPA, for 7 days experienced no change in urinary BPA levels and reported difficulty in avoiding the endocrine-disrupting chemical, according to findings published in BMJ Open.

The FDA recently approved expanding the indication for Ferring’s subcutaneous somatropin 5 mg and 10 mg recombinant human growth hormone to include replacement of growth hormone in adults with growth hormone deficiency, according to a press release from Ferring.

An analysis of more than 150 store receipts revealed that most no longer contain the endocrine-disrupting chemical bisphenol A; however, many now contain bisphenol S, which raises similar health concerns, according to a new report from the Ecology Center.

Women with infertility and Hashimoto’s thyroiditis who received levothyroxine supplementation for 3 months experienced an increase in anti-Müllerian hormone levels, a finding not observed in women with subclinical or overt hypothyroidism and infertility, according to findings reported in The Journal of Obstetrics and Gynaecology Research.

One year of transdermal estradiol plus micronized progesterone helped prevent the development of depressive symptoms more effectively than placebo among perimenopausal and early postmenopausal women, according to data published in JAMA Psychiatry.

The injectable progestin contraceptive depot medroxyprogesterone acetate, or DMPA, may raise the risk for HIV infection by 40% in women, according to a research review published in Endocrine Reviews.

Endocrine Today has compiled a list of the top five hormone therapy news reports posted in 2017.

The FDA has approved the oral ghrelin agonist macimorelin to be used in the diagnosis of patients with adult growth hormone deficiency, according to a press release from Aeterna Zentaris.